Nox1 and Nox4 Containing Oxidases are Required for PDGF-induced Migration of

描述（由申请方提供）：血管平滑肌细胞（VSMC）的迁移在心血管疾病进展中起重要作用。血管平滑肌细胞的迁移与动脉粥样硬化和血管成形术后由于增加的新生内膜形成而导致的再狭窄有关。最近的研究表明，血小板衍生生长因子（PDGF）刺激促进ROS的形成和VSMCs的迁移。ROS作为信号分子在细胞通路中调节迁移，但这些ROS的来源，调节其产生的机制，以及它们的下游靶点仍然不清楚。在这里，我提出了一个机制，Nox1和Nox4 NADPH氧化酶都需要VSMC迁移。我推测，PDGF诱导的VSMCs迁移需要基础的Nox4活性和Rac介导的Nox1刺激来调节粘着斑动力学和肌动蛋白细胞骨架。在这个建议中，我将通过三个目标来评估这个假设。在第一个目标，我将确定的机制，PDGF激活Rac刺激Nox 1和调节氧化还原敏感的信号通路，改变肌动蛋白聚合。在目标2中，我将评估Nox 4的表达和活性对Rho表达和Rho介导的VSMC粘着斑转换的作用。第三个也是最后一个目标将通过研究Nox4在新生血管形成中的作用来测试这些概念中的一些。了解PDGF诱导VSMC迁移的机制对于开发治疗策略以对抗心血管疾病非常重要。

DESCRIPTION (provided by applicant): Migration of vascular smooth muscle cells (VSMCs) plays an important role in cardiovascular disease progression. The migration of VSMCs is associated with atherosclerosis and restenosis after angioplasty due to increased neointima formation. Recent studies demonstrate that platelet derived growth factor (PDGF) stimulation promotes ROS formation and migration of VSMCs. ROS act as signaling molecules in cellular pathways that modulate migration, but the source of these ROS, the mechanisms regulating their production, and their downstream targets remain unclear. Here I propose a mechanism by which both Nox1 and Nox4 NADPH oxidases are required for VSMC migration. I hypothesize that PDGF-induced migration in VSMCs requires basal Nox4 activity and Rac-mediated stimulation of Nox1 to modulate focal adhesion dynamics and the actin cytoskeleton. In this proposal, I will evaluate this hypothesis via three aims. In the first aim, I will determine the mechanism by which PDGF activates Rac to stimulate Nox1 and modulate redox sensitive signaling pathways that alter actin polymerization. In aim 2, I will evaluate the role of Nox4 expression and activity on Rho expression and Rho-mediated focal adhesion turnover in VSMCs. The third and final aim will test some of these concepts in vivo by examining the role of Nox4 in neoinitmal formation. Understanding the mechanism by which PDGF induces VSMC migration is very important to developing therapeutic strategies to combat cardiovascular disease.